Treatment of chronic hypoparathyroidism by Eneboparatide, a novel PTH receptor-1 agonist: Results from a phase 2a study

Endocrine Abstracts（2023）

引用 0|浏览5

暂无评分

摘要

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

查看译文

关键词

chronic hypoparathyroidism,eneboparatide

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要